MURA Stock Summary and Trading Ideas (Mural Oncology PLC - | NASDAQ:MURA)

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Mural Oncology PLC - trades on the NASDAQ stock market under the symbol MURA.

As of January 5, 2026, MURA stock price was flat at $2.04 with million shares trading.

MURA has a beta of -0.26, meaning it tends to be less sensitive to market movements. MURA has a correlation of 0.00 to the broad based SPY ETF.

MURA has a market cap of $35.38 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that MURA belongs to (by Net Assets): VXF.

MURA has underperformed the market in the last year with a price return of -36.3% while the SPY ETF gained +18.9%. MURA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.4% and 0.0%, respectively, while the SPY returned +3.1% and +1.0%, respectively.

MURA support price is $2.04 and resistance is $2.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MURA shares will trade within this expected range on the day.